Medicine and Dentistry
Patient
100%
Myelodysplastic Syndrome
38%
Donor
36%
Hematopoietic Stem Cell Transplantation
27%
Disease
25%
T Cell
22%
Adult
21%
Acute Myeloid Leukemia
21%
Secondary Acute Myeloid Leukemia
21%
Acute Leukemia
21%
Acute B-Cell Lymphoblastic Leukemia
21%
Allogeneic Stem Cell Transplantation
21%
Therapeutic Procedure
20%
Analysis
20%
Follow up
19%
Transplantation
18%
Donor Lymphocyte Infusion
15%
Sibling
14%
Allogeneic Hematopoietic Stem Cell Transplantation
14%
Thymocyte Antibody
13%
Chimeric Antigen Receptor T-Cell Immunotherapy
11%
Therapeutics
11%
Follicular Lymphoma
10%
Cell Lineage
10%
Hazard Ratio
10%
Pediatrics
10%
Gut
10%
Multiple Sclerosis
10%
Graft Versus Leukemia Effect
10%
Overall Survival
10%
Cumulative Incidence
6%
Recurrence Risk
6%
Alternative Donor
5%
Myeloproliferative Neoplasm
5%
Chronic Myelomonocytic Leukemia
5%
Spontaneous Remission
5%
Immunology and Microbiology
Graft-Versus-Host Disease
64%
Transplant Procedure
10%
Cytotoxic T-Cell
10%
B Cell
10%
Cell Lineage
10%
Vedolizumab
8%
Stem Cell Transplant
7%
Bone Marrow
5%